RL
72
4
PAYX
53
2
WFC
79
4
MET
72
5
DNB
82
4
AN
58
4
JWN
48
6
ROK
62
15
FLR
58
3
IPG
56
3
PM
62
-2
KLAC
47
4
CL
58
2
NEE
50
-5
WBA
48
4
SWK
64
5
PSA
58
2
WM
79
3
FE
50
-2
CPB
30
6
RL
72
4
PAYX
53
2
WFC
79
4
MET
72
5
DNB
82
4
AN
58
4
JWN
48
6
ROK
62
15
FLR
58
3
IPG
56
3
PM
62
-2
KLAC
47
4
CL
58
2
NEE
50
-5
WBA
48
4
SWK
64
5
PSA
58
2
WM
79
3
FE
50
-2
CPB
30
6
Financhill
Back

Integra Lifesciences Holdings 10K Form

Sell
37

IART
Integra Lifesciences Holdings

Last Price:
23.55
Seasonality Move:
15.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-06 10Q IART/Integra Lifesciences Holdings Quarterly
2023-10-25 10Q IART/Integra Lifesciences Holdings Quarterly
2023-07-27 10Q IART/Integra Lifesciences Holdings Quarterly
2023-04-26 10Q IART/Integra Lifesciences Holdings Quarterly
2022-10-26 10Q IART/Integra Lifesciences Holdings Quarterly
2022-07-27 10Q IART/Integra Lifesciences Holdings Quarterly

Receive IART News And Ratings

See the #1 stock for the next 7 days that we like better than IART

IART Financial Statistics

Sales & Book Value

Annual Sales: $1.54B
Cash Flow: $-7.16M
Price / Cash Flow: 47.98
Annual Sales: $19.73
Price / Book: 1.2

Profitability

EPS (TTM): -0.09000
Net Income (TTM): $-6.54M
Gross Margin: $884.74M
Return on Equity: -0.42%
Return on Assets: -0.17%

Integra Lifesciences Holdings Earnings Forecast

Key Integra Lifesciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 29 years for IART is 57.39%.
  • The Selling, General & Administrative Expenses for IART have been equal to 42.60% of Gross Profit Margin.
  • The Research & Development expenses have been 6.76% of Revenue.
  • The Interest Expense is 75.84% of Operating Income.
  • The Net Earning history of IART is 4.39% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Integra Lifesciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: IART
CUSIP: 457985
Website: integralife.com

Debt

Debt-to-Equity Ratio: 1.19
Current Ratio: 1.2
Quick Ratio: 0.58

Price-to-Earnings

Trailing P/E Ratio: 28.07
Forward P/E Ratio: 9.39

IART Technical Analysis vs Fundamental Analysis

Sell
37
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings a Buy or a Sell?